FDAnews
www.fdanews.com/articles/131084-talecris-biotherapeutics-receives-fda-approval-for-gamunex-c

Talecris Biotherapeutics Receives FDA Approval for Gamunex-C

October 14, 2010
Talecris Biotherapeutics announced Thursday that the U.S. Food and Drug Administration approved Gamunex-C for subcutaneous administration in the treatment of primary immunodeficiency.
TradingMarkets